Canntab Therapeutics: Funding, Investors & Team (Sep 2026)
Canntab Therapeutics Ltd is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.
Canntab Therapeutics has raised $1.0M across 1 funding round on record, the most recent a Post-IPO Debt of $1.0M announced in Feb 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Canntab Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2022.
Canntab Therapeutics Funding Rounds
Canntab Therapeutics Founders and Leadership Team
Contact details for the Canntab Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Canntab Therapeutics Funding Compared to Other Biotechnology Startups
Canntab Therapeutics' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Canntab Therapeutics in Biotechnology and Markham
Companies Similar to Canntab Therapeutics
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Canntab Therapeutics Funding FAQs
What does Canntab Therapeutics do?
Canntab Therapeutics Ltd is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.
How much funding has Canntab Therapeutics raised?
Canntab Therapeutics has raised $1.0M across 1 round on record. The most recent is a Post-IPO Debt of $1.0M announced in Feb 2022.
When did Canntab Therapeutics last raise funding?
Canntab Therapeutics' most recent funding round on record is a Post-IPO Debt of $1.0M, announced in Feb 2022.
Who is the CEO of Canntab Therapeutics?
Jeff Renwick is listed as CEO at Canntab Therapeutics.
Where is Canntab Therapeutics headquartered?
Canntab Therapeutics is based in Markham, Ontario, Canada.
How many employees does Canntab Therapeutics have?
Canntab Therapeutics is in the 11-50 employee band.
How does Canntab Therapeutics' funding compare to other Biotechnology startups?
Canntab Therapeutics' latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Canntab Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Canntab Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.